TELA Bio Statistics
Share Statistics
TELA Bio has 39.55M
shares outstanding. The number of shares has increased by 60.42%
in one year.
| Shares Outstanding | 39.55M |
| Shares Change (YoY) | 60.42% |
| Shares Change (QoQ) | 0.41% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 574 |
| FTD / Avg. Volume | 0.22% |
Short Selling Information
The latest short interest is 671.93K, so 1.7% of the outstanding
shares have been sold short.
| Short Interest | 671.93K |
| Short % of Shares Out | 1.7% |
| Short % of Float | 2.15% |
| Short Ratio (days to cover) | 7.25 |
Valuation Ratios
The PE ratio is -2.28 and the forward
PE ratio is -3.51.
TELA Bio's PEG ratio is
0.07.
| PE Ratio | -2.28 |
| Forward PE | -3.51 |
| PS Ratio | 1.24 |
| Forward PS | 0.4 |
| PB Ratio | 3.03 |
| P/FCF Ratio | -2.02 |
| PEG Ratio | 0.07 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for TELA Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.01,
with a Debt / Equity ratio of 1.46.
| Current Ratio | 5.01 |
| Quick Ratio | 4.19 |
| Debt / Equity | 1.46 |
| Debt / EBITDA | -1.32 |
| Debt / FCF | -0.98 |
| Interest Coverage | -6.45 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $331,578.95 |
| Profits Per Employee | $-181,057.42 |
| Employee Count | 209 |
| Asset Turnover | 0.8 |
| Inventory Turnover | 1.78 |
Taxes
| Income Tax | -144K |
| Effective Tax Rate | 0.38% |
Stock Price Statistics
The stock price has increased by -74.39% in the
last 52 weeks. The beta is 0.67, so TELA Bio's
price volatility has been higher than the market average.
| Beta | 0.67 |
| 52-Week Price Change | -74.39% |
| 50-Day Moving Average | 1.2 |
| 200-Day Moving Average | 2.38 |
| Relative Strength Index (RSI) | 70.94 |
| Average Volume (20 Days) | 259,043 |
Income Statement
In the last 12 months, TELA Bio had revenue of 69.3M
and earned -37.84M
in profits. Earnings per share was -1.33.
| Revenue | 69.3M |
| Gross Profit | 46.49M |
| Operating Income | -34.12M |
| Net Income | -37.84M |
| EBITDA | -31.68M |
| EBIT | -32.7M |
| Earnings Per Share (EPS) | -1.33 |
Full Income StatementBalance Sheet
The company has 52.67M in cash and 41.67M in
debt, giving a net cash position of 11M.
| Cash & Cash Equivalents | 52.67M |
| Total Debt | 41.67M |
| Net Cash | 11M |
| Retained Earnings | -358.73M |
| Total Assets | 77.25M |
| Working Capital | 53.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -41.59M
and capital expenditures -989K, giving a free cash flow of -42.58M.
| Operating Cash Flow | -41.59M |
| Capital Expenditures | -989K |
| Free Cash Flow | -42.58M |
| FCF Per Share | -1.49 |
Full Cash Flow StatementMargins
Gross margin is 67.08%, with operating and profit margins of -49.23% and -54.6%.
| Gross Margin | 67.08% |
| Operating Margin | -49.23% |
| Pretax Margin | -54.81% |
| Profit Margin | -54.6% |
| EBITDA Margin | -45.72% |
| EBIT Margin | -49.23% |
| FCF Margin | -61.45% |
